- Home
- SCWO vs HOWL Comparison
SCWO vs HOWL Comparison
Compare SCWO & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- HOWL
- Stock Information
- Founded
- SCWO 2021
- HOWL 2017
- Country
- SCWO United States
- HOWL United States
- Employees
- SCWO N/A
- HOWL N/A
- Industry
- SCWO Environmental Services
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- SCWO Utilities
- HOWL Health Care
- Exchange
- SCWO Nasdaq
- HOWL Nasdaq
- Market Cap
- SCWO 58.8M
- HOWL 64.5M
- IPO Year
- SCWO N/A
- HOWL 2021
- Fundamental
- Price
- SCWO $0.35
- HOWL $1.43
- Analyst Decision
- SCWO
- HOWL Strong Buy
- Analyst Count
- SCWO 0
- HOWL 5
- Target Price
- SCWO N/A
- HOWL $7.20
- AVG Volume (30 Days)
- SCWO 1.1M
- HOWL 147.5K
- Earning Date
- SCWO 11-12-2025
- HOWL 11-06-2025
- Dividend Yield
- SCWO N/A
- HOWL N/A
- EPS Growth
- SCWO N/A
- HOWL N/A
- EPS
- SCWO N/A
- HOWL N/A
- Revenue
- SCWO $1,231,413.00
- HOWL N/A
- Revenue This Year
- SCWO $5,945.19
- HOWL N/A
- Revenue Next Year
- SCWO $106.82
- HOWL N/A
- P/E Ratio
- SCWO N/A
- HOWL N/A
- Revenue Growth
- SCWO 403.17
- HOWL N/A
- 52 Week Low
- SCWO $0.16
- HOWL $0.60
- 52 Week High
- SCWO $1.95
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- SCWO 55.11
- HOWL 61.71
- Support Level
- SCWO $0.37
- HOWL $1.29
- Resistance Level
- SCWO $0.41
- HOWL $1.49
- Average True Range (ATR)
- SCWO 0.05
- HOWL 0.07
- MACD
- SCWO 0.00
- HOWL 0.01
- Stochastic Oscillator
- SCWO 52.94
- HOWL 70.00
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.